Related Experiment Video
Updated: Feb 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The Genetics of Aortopathies in Clinical Cardiology
Amit Goyal1, Ali R Keramati2, Matthew J Czarny2
1Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Insights
Heritable aortopathies, including Marfan syndrome, are genetic disorders causing early death. Next-generation sequencing advances understanding of their causes and guides new treatments.
Area of Science:
- Cardiovascular Genetics
- Medical Genetics
- Molecular Pathophysiology
Background:
- Aortopathies represent a significant health concern, characterized by high mortality rates, rising incidence, and frequent underdiagnosis.
- Genetic factors are increasingly recognized as primary drivers of many aortopathies, necessitating a deeper understanding of their molecular basis.
- Effective management strategies rely on early diagnosis, continuous surveillance, and proactive interventions.
Purpose of the Study:
- To review the current understanding of pathogenetic mechanisms in heritable genetic aortopathies.
- To summarize the latest management strategies for these complex conditions.
- To highlight the role of genetic discoveries in identifying therapeutic targets.
Main Methods:
- Comprehensive literature review focusing on genetic aortopathies.
- Analysis of recent advancements in next-generation sequencing (NGS) applications.
- Synthesis of data on syndromic and nonsyndromic forms of heritable aortopathies.
Main Results:
- NGS has significantly expanded the identification of genetic variants underlying heritable aortopathies.
- Clarification of molecular pathophysiology provides insights into disease progression.
- Identification of specific disorders such as Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and familial thoracic aortic aneurysm and dissection.
Conclusions:
- Genetic insights are crucial for diagnosing and managing heritable aortopathies.
- Early detection, surveillance, and prophylactic repair are essential for improving patient outcomes.
- Ongoing research into molecular mechanisms promises novel therapeutic avenues for these life-threatening conditions.
Abstract:
Aortopathies pose a significant healthcare burden due to excess early mortality, increasing incidence, and underdiagnosis. Understanding the underlying genetic causes, early diagnosis, timely surveillance, prophylactic repair, and family screening are keys to addressing these diseases. Next-generation sequencing continues to expand our understanding of the genetic causes of heritable aortopathies, rapidly clarifying their underlying molecular pathophysiology and suggesting new potential therapeutic targets. This review will summarize the pathogenetic mechanisms and management of heritable genetic aortopathies with attention to specific forms of both syndromic and nonsyndromic disorders, including Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and familial thoracic aortic aneurysm and dissection.
More Related Videos
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Aneurysm I: Introduction
Aortic Regurgitation I: Introduction
Coronary Artery Disease I: Introduction

